- Home
- Publications
- Publication Search
- Publication Details
Title
Prospects for the Use of Cannabinoids in Psychiatric Disorders
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-12
DOI
10.3389/fpsyt.2021.620073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
- (2020) Tibor Stark et al. BIOCHEMICAL PHARMACOLOGY
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats
- (2020) Martina Di Bartolomeo et al. PHARMACOLOGICAL RESEARCH
- Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
- (2019) Tomasz Dzierżanowski Cancers
- The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice
- (2019) Vincenzo Micale et al. Frontiers in Pharmacology
- Positive and Negative Effects of Cannabis and Cannabinoids on Health
- (2019) Koby Cohen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
- (2019) Yasmin L. Hurd et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly
- (2018) Ran Abuhasira et al. European Journal of Internal Medicine
- Endocannabinoid system, Stress and HPA axis
- (2018) Vincenzo Micale et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus
- (2017) Vincenzo Micale et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Cannabis use and risk of schizophrenia: a Mendelian randomization study
- (2017) J Vaucher et al. MOLECULAR PSYCHIATRY
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- Cannabis, Cannabinoids, and Sleep: a Review of the Literature
- (2017) Kimberly A. Babson et al. Current Psychiatry Reports
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Association Between Cannabis and Psychosis: Epidemiologic Evidence
- (2016) Suzanne H. Gage et al. BIOLOGICAL PSYCHIATRY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
- (2016) Erin C. Hanlon et al. SLEEP
- Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
- (2016) Erin C. Hanlon et al. SLEEP
- 2012 Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome: Executive Summary
- (2016) Mary-Ann Fitzcharles et al. Pain Research & Management
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Safety of oral dronabinol during opioid withdrawal in humans
- (2015) Crystal J. Jicha et al. DRUG AND ALCOHOL DEPENDENCE
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
- (2015) E. C. Hanlon et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial
- (2015) G. A. H. van den Elsen et al. NEUROLOGY
- Neurobiological Interactions Between Stress and the Endocannabinoid System
- (2015) Maria Morena et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons
- (2015) Alvaro Llorente-Berzal et al. PSYCHOPHARMACOLOGY
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- Medical Marijuana Laws and Suicides by Gender and Age
- (2014) D. Mark Anderson et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice
- (2014) Ana Luisa B. Terzian et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis
- (2014) Tibor M. Brunt et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage
- (2014) Miriam Fishbein-Kaminietsky et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Stress regulates endocannabinoid-CB1 receptor signaling
- (2014) Cecilia J. Hillard SEMINARS IN IMMUNOLOGY
- Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal
- (2013) J.L. Scavone et al. NEUROSCIENCE
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses
- (2011) Arnau Busquets-Garcia et al. BIOLOGICAL PSYCHIATRY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life
- (2011) Jimena Fiz et al. PLoS One
- The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
- (2011) Ana Luisa Terzian et al. Frontiers in Behavioral Neuroscience
- The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
- (2010) Mark A. Ware et al. ANESTHESIA AND ANALGESIA
- Symptomatology and Neuropsychological Functioning in Cannabis Using Subjects at Ultra-High Risk for Developing Psychosis and Healthy Controls
- (2010) Nikie Korver et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Psychosis reactivity to cannabis use in daily life: an experience sampling study
- (2010) Cécile Henquet et al. BRITISH JOURNAL OF PSYCHIATRY
- Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
- (2010) M. A. Ware et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Opioids and Cannabinoids Interactions: Involvement in Pain Management
- (2010) Julie Desroches et al. CURRENT DRUG TARGETS
- Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
- (2010) D. Parolaro et al. CURRENT DRUG TARGETS
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
- (2009) George A. Fraser CNS Neuroscience & Therapeutics
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
- (2009) Dagmar Koethe et al. JOURNAL OF NEURAL TRANSMISSION
- Cannabis and psychiatric disorders: it is not only addiction
- (2008) F. Markus Leweke et al. ADDICTION BIOLOGY
- Effects of cannabis use on outcomes of psychotic disorders: systematic review
- (2008) Stanley Zammit et al. BRITISH JOURNAL OF PSYCHIATRY
- The cannabinoid CB1receptor and the endocannabinoid anandamide: possible antidepressant targets
- (2008) Francis Rodriguez Bambico et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabinoid Receptors: Where They are and What They do
- (2008) K. Mackie JOURNAL OF NEUROENDOCRINOLOGY
- Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder
- (2008) Michael J. Zvolensky et al. JOURNAL OF PSYCHIATRIC RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now